Biofourmis scores another $20M and more digital health fundings

AI-backed remote monitoring and digital therapeutics company Biofourmis added another $20 million to its Series D round, bringing its raise to $320 million.

The extension funding comes from Intel Capital, the strategic investment division of chipmaker Intel. The company first announced its